TPB) (NYSE: Brands Point Turning

INVESTOR PRESENTATION

Q 3 2 0 2 0

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

Disclaimer

FORWARD LOOKING STATEMENTS

This presentation contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, actual events may differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause these differences include, but are not limited to, the factors set forth in "Risk Factors" included in TPB's annual report on Form 10-K and other reports filed with the Securities and Exchange Commission from time to time. Any forward-looking statement made by TPB in this presentation speaks only as of the date hereof. New risks and uncertainties come up from time to time, and it is impossible for TPB to predict these events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws.

This presentation includes industry and market data derived from internal analyses based upon publicly available data or proprietary research and analysis, surveys or studies conducted by third parties and industry and general publications, including those by the Management Science Associates, Inc. ("MSAi") and Nielsen Holdings, N.V. ("Nielsen"). Third-party industry and general publications, research, surveys and studies generally state that the information contained therein has been obtained from sources believed to be reliable. Although there can be no assurance as to the accuracy or completeness of the included information, we believe that this information is reliable. While we believe our internal analyses are reliable, they have not been verified by any independent sources. Any such data and analysis involve risks and uncertainties and are subject to change based on various factors, including those set forth in "Risk Factors" included in TPB's annual report on Form 10-K and other reports filed with the Securities and Exchange Commission from time to time.

NON-GAAP RECONCILIATION

This presentation includes certain non-U.S. generally accepted accounting principles ("GAAP") financial measures, including EBITDA, Adjusted EBITDA and Net Debt. Such non-GAAP financial measures are not in accordance with, or an alternative to, financial measures prepared in accordance with GAAP. Please refer to the Appendix of this presentation for a reconciliation of EBITDA and Adjusted EBITDA to net income and Net Debt to Debt. To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures, including EBITDA, Adjusted EBITDA and Net Debt. We believe EBITDA and Adjusted EBITDA provide useful information to management and investors regarding certain financial and business trends relating to financial condition and results of operations. Adjusted EBITDA and Net Debt are used by management to compare performance to that of prior periods for trend analyses and planning purposes and is presented to our board of directors. We believe that EBITDA and Adjusted EBITDA are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to business performance.

Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. EBITDA and Adjusted EBITDA exclude significant expenses that are required by U.S. GAAP to be recorded in our financial statements and is subject to inherent limitations. In addition, other companies in our industry may calculate these non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure.

2

TPB: Investment Highlights

TPB Investment Highlights

Point Turning

Resilient

Core Business with

Leading Brands

NewGen

Value Creation Potential

Powerful

Distribution Infrastructure

Stable

Free Cash Flow Generation for Capital Deployment

    • MST product gaining share with long runway for distribution gains
    • Leading value brand in tobacco chew
    • #1 premium rolling paper brand with unparalleled brand recognition
    • Accelerating growth through new product and channel initiatives
  • Online distribution businesses gives access to new customers
  • PMTA process will consolidate vape market with TPB well positioned to gain share
  • Nu-XVentures product development engine: high-margin, proprietary products such as CBD, nutraceuticals, nicotine chew and modern oral pouches
  • Widespread presence and long-standing relationships in core convenience store channel
  • Increasing brand presence through non-traditional channels
  • Re-vampedbrand e-commerce platforms (ZigZag.com,Nu-X.com,SolaceVapor.com)
  • Leveraging distribution infrastructure for new product introductions and acquired brands
  • Asset-lightbusiness model leads to high free cash flow conversion for capital deployment
  • Acquisition of Durfort assets and investments in Wild Hempettes and dosist in 2020
  • Robust pipeline of acquisition opportunities

TPB) (NYSE: Brands

3

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

We are a consumer products company that markets products with active ingredients through iconic and emerging brands

BROAD PORTFOLIO OF ACTIVE INGREDIENT ALTERNATIVES AND BRANDS

4

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

Distribution Infrastructure

Powerful Distribution Infrastructure

North American retail presence that reaches over ~210,000 outlets + B2C online sites

TPB) (NYSE: Brands Point Turning

National

Regional

Product

B2C

B2B

Distribution

Sales Teams

Sales Teams

Distribution

Distribution

National sales team

Regional sales team selling

Dedicated product sales

Online B2C distribution

Online B2B platform

selling to over 85,000

to over 95,000 independent

teams and brand specific

platforms selling to ~1.5

reaching ~4,000

national chain stores

convenience stores

B2C/B2B platforms

million unique customers

alternative stores

zigzag.com

solacevapor.com

directvapor.com

vaporbeast.com

nu-x.com

solacechew.com

vaporfi.com

nu-xnutra.com

5

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

Smokeless: Stoker's Brand Equity

Smokeless: Iconic Brand with Sustained Growth

Brands Point Turning

About Stoker's

Building brand equity for

over 80 years. Stoker's is

the #1 loose-leaf chew

brand1 and a leading MST value brand

60%

Stoker's created the MST Tubs category and is the category leader with ~60%1 share

1. Per MSAi at the end of 3Q20.

MST TUBS

Introduced a larger tub format Moist Snuff Tobacco (MST) product driving category over the last 10+ years

MST Cans

Accelerating strength from

distribution gains and

same-store sales growth.

Significant chain launches

in 2019 and 2020

Chew

#1 discount and overall

loose-leaf chew brand in the

US1. TPB's brands

collectively hold ~32%1 of the

loose-leaf chew market

TPB) (NYSE:

6

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

Smokeless: Stoker's MST Distribution Growth

Smokeless: Continued MST

Distribution Gains

(NYSE: Brands Point Turning

66.1 67.6 68.3 70.4

61.4 61.6 61.3 62.3 63.2 63.1

57.0 57.7 58.0

52.2

48.1

41.4 43.0

72.8 74.9 76.8

Long Runway for Growth

Currently in stores representing ~59%1 of volume weighted distribution

Additional ~30-50k stores targeted for national distribution

TPB)

4Q15

2Q16

4Q16

2Q17

4Q17

2Q18

4Q18

2Q19

4Q19

2Q20

Store count excludes ~14k lower sales velocity Dollar General stores added in 2Q18.

1. Per MSAi at the end of 3Q20.

7

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

Zig-Zag: Brand Equity

Smoking: Iconic Brand with

Leading Market Share

About Zig-Zag

Papers

Wraps

New Product Launches

Embedded into pop culture

#1 premium rolling paper

Market leader in MYO cigar

Continued roll-out of paper

with a storied history that

brand sold in the U.S. 1 and

wraps with a majority share

cones, unbleached and hemp

dates over 140 years

Canada

of the market 1

rolling papers along with new

product introductions

TPB) (NYSE: Brands Point Turning

35%

Zig Zag owns >35%1 of

the rolling paper market in

the United States

1. Per MSAi at the end of 3Q20.

8

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

Zig-Zag: Growth Initiatives

Smoking: Expanding Portfolio

and Sales Channels

Classic Zig-Zag Products

Growth Initiatives

TPB) (NYSE: Brands Point Turning

Iconic Products with

Unparalleled Recognition

"Zig-Zag Orange" and "Zig-Zag White" are

long-standing industry staples

New products and accessories

Re-vampede-commerce platform

Enhanced brand presence in headshops and dispensaries; ReCreation Marketing partnership in Canada

9

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

Acquisition of Durfort Holdings Assets

Acquisition of assets of Durfort Holdings

Acquisition of assets from Durfort Holdings S.R.L. ("Durfort") in Q2 2020

  • Acquired a co-ownership interest in our long-term partner Durfort's intellectual property related to TPB's MYO cigar wraps and cones
  • $46 million purchase price ($36 million in cash and $10 million seller note)
  • $5 million net sales and $7 million EBITDA contribution on an annualized basis (mostly in COGS savings)

Increases Exposure to Attractive Zig-Zag MYO Cigar Wraps Product and Secures Long-Term Control

  • Benefitting from increased demand related to cannabis legalization and decriminalization in certain jurisdictions
  • Acquisition allowed TPB to realize higher gross margins by capturing more of the profitability by eliminating royalty- related payments for a growth product it already controls

More Direct Manufacturing Relationship

  • More direct relationship with third-party manufacturer allowing business to scale and align production with market demand

Master Distribution Agreement for Blunt Wrap USA

  • Adds complementary product to TPB's MYO cigar wrap offerings
  • Presents cross-selling synergy opportunities with product primarily sold in non-traditional channels where TPB products are currently under-represented
  • Distribution of Blunt Wraps began in October 2020

TPB) (NYSE: Brands Point Turning

10

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

NewGen Segment

NewGen: Proprietary Products Growth

Executing on a multi-year journey to increase proprietary products sales in the NewGen segment

Proprietary product gross margins (50%+) exceed third-party product gross margins (20% - 40%)

TPB) (NYSE: Brands Point Turning

2016

2017

2018

2019

Acquired VaporBeast,

Acquired VaporShark,

Acquired IVG,

Acquired Solace, a

leading third-party B2B

one of the first

expanding B2C

leading proprietary

distributor of open

proprietary vaping

distribution including

open systems vaping

systems vaping

brands

proprietary VaporFi

brand; and launched

products

brand and the Direct

Nu-X, a development

Vapor platform

engine for non-vape

proprietary actives

Proprietary Products as % of Net Sales1

products

1%

~5%

~10%

~17%

1. Excludes V2 and RipTide.

2020

Submitted applications covering 250 products through the FDA PMTA process that will consolidate the market; Invested in Wild Hempettes to become its exclusive distributor

YTD Q3: ~20%

2021-2023

Continue expanding proprietary growth through new introductions on Nu-X and significant SKU consolidation in the vaping market

Target 50%+

11

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

Nu-X New Product Portfolio

Robust Pipeline of New Product Introductions

Nu-X: New Product Portfolio

Brands Point Turning

Nu-X Nutra

Caffeine B12 - Café Disposable

Caffeine B12 - Energy Disposable

Caffeine B12 - Tablets

Cannabinoids

Pet CBD Tincture

CBG Tinctures

CBN Tinctures

CBD Tinctures 16.5ml

CBD Pre-Rolls

CBG Flower

CBD Awake Shot

CBD Relax Shot

CBD Hemperettes

CBD Lip Balm

CBD Muscle/Joint Topical

CBD Youth Serum

CBD Gummies

Nicotine Chew

Solace Chew - Mint 4mg Solace Chew - Cinnamon 4mg Solace Chew - Fruit 4mg

Modern Oral Pouches

Fré 9mg and 12mg - Mocha

Fré 9mg and 12 mg - Mint

Fré 9mg and 12mg - Lush

RipTide

G2 Battery

Nicotine Salt Menthol Pod

Nicotine Salt Tobacco Pod

CBD TFN Pod

Solace

35 unique flavors in

5 nicotine strength variants filed PMTAs

TPB) (NYSE:

12

TPB: Navigating Regulated Environments

Management of Regulatory Environments

Extensive experience managing regulatory regime changes

REGULATORY STRATEGY

  • TPB does not sell cigarettes, the primary target of the FDA
  • Concentrated effort to shape premarket pathway for future innovation
  • Experienced team of QA, R&D, legal and scientific professionals
  • Building consensus among like-minded small and mid-sized businesses to drive policy
  • Increased regulation rationalizes market in favor of those who can navigate shifting regulation

• Invested ~$17 million to support an extensive portfolio of products through the PMTA process

TPB) (NYSE: Brands Point Turning

TPB has unique capabilities to get proprietary brands through regulatory regime changes

  • FDA's PMTA process is a transformational regulatory process that likely consolidates the vape market
  • Submitted applications for 250 products ahead of the PMTA deadline on September 9, 2020
  • NewGen is well-positioned for growth in a post-PMTA environment with its extensive product portfolio

13

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

Strategic Investments dosist and Wild Hempettes

dosist - announced $15 million strategic investment on October 27, 2020

  • Leading globally recognized cannabis brand with powerful marketing organization
  • Products currently available in CA, CO, NV and Canada with plans for further expansion
  • Expanding offerings from disposable pens to rechargeable pens and other form factors
  • Exclusive co-development and distribution agreement of a new national CBD brand, created in partnership with dosist's thc-free business unit targeting the c-store channel
  • Option to invest another $15 million at pre-determined terms within the next 12 months
  • US legal cannabis market projected to grow from $16 billion in 2020E to $34 billion by 20251

Wild Hempettes - announced acquisition of 20% stake on October 5, 2020

  • Leading manufacturer of hemp cigarettes under the WildHemp™ and Hempettes™ brands
  • Exclusive distribution agreement under a profit-sharing agreement where TPB will extend the product's reach through its sales infrastructure
  • Options to increase stake to a 100% ownership position based on certain milestones
  • Smokable hemp CBD market expected to grow from $70-80 million in 2020E to $300-400 million by 20252

Focus on value-accretive investments that extend TPB's reach into

large and growing addressable markets

  1. Source: Arcview Research/BDSA August 2020
  2. Source: Nielsen Research September 2020

Strategic Investments

TPB) (NYSE: Brands Point Turning

14

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

Segment Breakdown

Total Sales and Segment Breakdown

Internal initiatives leading to accelerated organic growth in our core segments

Brands Point Turning

2016

2017

2018

2019

9mo 19

9mo 20

YoY

Smokeless (Stoker's)

Looseleaf

$47

$49

$48

$46

$34

$36

6%

MST

31

35

42

54

41

51

25%

Total Smokeless

$78

$85

$90

$100

$75

$87

16%

Smoking (Zig-Zag)

Wraps

$46

$47

$49

$52

$40

$43

6%

US Papers1

36

38

38

38

28

38

38%

Canadian Papers

11

12

14

11

7

7

-8%

Core Smoking

$93

$96

$102

$102

$75

$88

17%

Other (Non-Core)2

18

14

10

7

6

4

-22%

Total Smoking

$111

$110

$112

$109

$81

$92

14%

Total NewGen

$17

$91

$131

$153

$126

$120

-4%

Total Net Sales

$206

$286

$333

$362

$282

$300

6%

Note: $ in millions.

  1. Includes Zig-Zage-commerce sales
  2. Includes de-emphasizedlow-margin products including MYO / pipe products (discontinued in 1Q20) and Cigars.

Smokeless (Stoker's) Drivers

  • Looseleaf: Targeted sales initiatives in 2020
  • MST: Same-store sales growth and long runway for distribution ramp

Smoking (Zig-Zag) Drivers

  • Industry levered to cannabis consumption
  • Alternative channel penetration (headshops and dispensaries) and e-commerce ramp
  • Wraps: Blunt Wraps distribution and new product introductions in 2021
  • US Papers: New product ramp-up (eg cones)
  • Canada: Alternative channel growth (Rec Marketing) and recent price increase (Q4 20)
  • Non-Core: Declines less of a headwind

NewGen Drivers

  • PMTA causing short-term disruption but creating tremendous long-term opportunity
  • Nu-Xnew product introductions driving proprietary products mix higher

TPB) (NYSE:

15

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

TPB Earnings Performance

Robust Adjusted EBITDA growth with significant acceleration expected for 2020

2016 - 2020E Adjusted EBITDA CAGR: ~14%*

$87-90*

TPB: Financial Summary

TPB) (NYSE: Brands Point Turning

$64.6

$60.0

$52.4

$67.3

2016

2017

2018

2019

2020E

Note: $ in millions. Reference GAAP reconciliation in Appendix.

*2020E estimate based on guidance provided on October 27, 2020; CAGR based on mid-point of guidance

16

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

Building a Capital Efficient Business Model

Asset-lightbusiness model that generates significant free cash flow

Asset-Light Business Model

Brands Point Turning

Initiatives:

  • Outsourced manufacturing of most products except Stoker's
    MST supports our asset-light model
  • Capital efficiency enables investment in sales force

ADJUSTED EBITDA VS. CAPITAL EXPENDITURES

Adjusted EBITDA1

Capital Expenditures

$64.6$67.3

$60.0

$52.4

TPB) (NYSE:

Results:

Significant cash flow

expansion (a proven revenue driver), working capital and infrastructure to support new product launches

  • Re-deploycash flow from recession-resistant, traditional tobacco business for accretive acquisitions and strategic investments

$3.2

$2.0

$2.3

$4.8

2016

2017

2018

2019

available to

reinvest in

the business

Note: $ in millions.

1. Reference GAAP reconciliation in Appendix.

17

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

Recent Business Highlights

Recent Business Highlights

Strong recent performance is a result of tactical repositioning of the business over the last 12 months and executing on this plan

Q3 2020

• Net Sales of $104 million versus late-July guidance of $90 to $95 million with core segments outperforming

• Announced investments in Wild Hempettes and dosist

Highlights

• 2020 Guidance increased again

• 2020 Net Sales $395 to $401 million (vs previous guidance of $353 to $370 million)

• 2020 Adjusted EBITDA of $87 million to $90 million (vs previous guidance of $78 to $83 million)

• Q4 Net Sales of $95 to $101 million

Why We

• Internal growth initiatives are driving a majority of the growth with core businesses outpacing market growth

• Consumer down-trading benefitting Stoker's; increased cannabis consumption benefitting rolling paper market

Are Winning

• Operating leverage: Streamlining the business (announced 11/2019) has led to $10 million in SG&A cost savings

• Value-accretive capital deployment: Durfort assets, Wild Hempettes, dosist and opportunistic share repurchases

• ~$100 million in liquidity leaves us well capitalized to take advantage of market opportunities

TPB) (NYSE: Brands Point Turning

Management is focused on executing on its plan for growth during

and after COVID-19 related impacts

18

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

2020 in Focus: Strategies and Objectives

Maximize the Core Business

  • Drive Stoker's MST growth through increased distribution and same-store-sales growth
  • Expand Zig-Zag's reach with new product introductions, channel specific strategies and e-commerce initiatives

Position NewGen for Profitable Growth

  • Streamline vaping, maintain profitability while investing in new products via the PMTA process
  • Introduce products from Nu-X Ventures into companywide distribution infrastructure

2020 Objectives

TPB) (NYSE: Brands Point Turning

Drive Cost Efficiency

  • Increased operating leverage through solid cost controls and spending efficiencies to deliver higher ROIC

Introduce Proprietary Products

  • Identify and develop emerging product forms that consumers are increasingly gravitating towards (eg modern oral)

Engage in Strategic Acquisitions

  • Efficiently deploy capital on accretive acquisitions to accelerate company growth
  • Execute on Blunt Wraps and Wild Hempettes distribution and dosist thc-free brand development

19

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

TPB) (NYSE: Brands Point Turning

Appendix

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

GAAP Reconciliation

Reconciliation of GAAP Net Income to Adjusted EBITDA

($ in millions)

2016

2017

2018

2019

Net income attributable to Turning Point Brands, Inc.

$26.9

$20.2

$25.3

$13.8

Add:

Interest expense, net

$26.6

$16.9

$14.8

$17.3

Loss on extinguishment of debt

2.8

6.1

2.4

1.3

Income tax expense

(12.0)

7.3

6.3

2.0

Depreciation expense

1.2

1.6

2.1

2.6

Amortization expense

0.1

0.7

1.0

1.5

EBITDA

$45.6

$52.8

$51.9

$38.6

Components of Adjusted EBITDA

Other (a)

$1.5

$1.3

$0.4

$0.4

Stock options, restricted stock, and incentives expense (b)

0.2

0.7

1.4

4.6

Transactional expenses and strategic initiatives (c)

1.6

2.1

4.5

1.8

New product launch costs (d)

2.7

2.4

1.8

6.2

FDA PMTA (e)

0.0

0.0

0.0

2.2

Corporate and vapor restructuring (f)

0.0

0.6

4.6

19.2

Vendor settlement (g)

0.0

0.0

0.0

(5.5)

Bonus (h)

0.9

0.1

0.0

0.0

Adjusted EBITDA

$52.4

$60.0

$64.6

$67.3

  1. Represents LIFO adjustment, non-cash pension expense (income) and foreign exchange hedging.
  2. Represents non-cash stock options, restricted stock, incentives expense and Solace PRSUs.
  3. Represents the fees incurred for transaction expenses and strategic initiatives.
  4. Represents product launch costs for our new product lines.
  5. Represents costs associated with applications related to FDA PMT A.
  6. Represents costs associated with corporate and vapor restructuring including severance and inventory reserves.
  7. Represents net gain associated with the settlement of a vendor contract.
  8. Represents bonuses associated with the December 2017 T ax Cuts and Jobs Act and non-recurring compensation expenses incurred coinciding with the May 2016 IPO.

GAAP Reconciliation

TPB) (NYSE: Brands Point Turning

21

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

TPB) (NYSE: Brands Point Turning

T H A N K Y O U

| N Y S E : T P B | 5 2 0 1 I N T E R C H A N G E W A Y , L O U I S V I L L E K Y | T U R N I N G P O I N T B R A N D S . C O M |

Attachments

  • Original document
  • Permalink

Disclaimer

Turning Point Brands Inc. published this content on 27 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 October 2020 11:39:04 UTC